Company intelligence / Profile preview

Avextra

Ownership: Private
Development stage: Commercial

Overview

Avextra has established itself as one of Europe’s leading vertically integrated medical cannabis companies. It controls the entire value chain from cultivation in Portugal to EU-GMP certified extraction/manufacturing in Germany. The company invests heavily in R&D (~one-third of budget), collaborates closely with researchers/clinicians, runs both real-world evidence studies and RCTs targeting significant unmet needs such as oncology symptom relief and chronic pain. In addition to its own pipeline of cannabis-derived medicines, it has entered into partnerships for novel psychedelic therapeutics.

Therapeutic areas: OncologyNeurologyOther
Modalities: Plant-based medicines (cannabis-based medicinal products)Full-spectrum cannabinoid oils and extractsPsilocybin-based compounds (in partnership)
Industry: Biotech

Drug pipeline

2 assets

Avextra 10/10

1 more asset in the full pipeline.

Request access →

Partnerships

SynQube GmbH – strategic partnership for drug development involving psilocybin clinical trial starting in the EU from 2025.Collaborations with German Pain Association/DGSacademic/research alliances through the “Avextra Alliance for Evidence.”

Beyond the preview

Go deeper on Avextra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avextra.

Explore the full profile